Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration Patients

GlycA, a novel pro‐inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta‐analysis

(2019) E. G. Gruppen et al.   JOURNAL OF INTERNAL MEDICINE

GlycA, a composite low‐grade inflammatory marker, predicts mortality: prime time for utilization?

(2019) D. A. Duprez et al.   JOURNAL OF INTERNAL MEDICINE

Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts

(2018) Juho Tynkkynen et al.   Alzheimers & Dementia

Low Prevalence of Cancer in Patients with Frontotemporal Lobar Degeneration

(2018) Kasper Katisko et al.   JOURNAL OF ALZHEIMERS DISEASE

Prevalence of immunological diseases in a Finnish frontotemporal lobar degeneration cohort with the C9orf72 repeat expansion carriers and non-carriers

(2018) Kasper Katisko et al.   JOURNAL OF NEUROIMMUNOLOGY

Polygenic link between blood lipids and amyotrophic lateral sclerosis

(2018) Xu Chen et al.   NEUROBIOLOGY OF AGING

Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies

(2018) Iris Broce et al.   PLOS MEDICINE

Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development

(2018) Woojin Scott Kim et al.   Frontiers in Neurology

C9orf72-mediated ALS and FTD: multiple pathways to disease

(2018) Rubika Balendra et al.   Nature Reviews Neurology

Causal Effects of Blood Lipids on Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study

(2018) Ping Zeng et al.   HUMAN MOLECULAR GENETICS

The Association Between Frontotemporal Lobar Degeneration and Bullous Pemphigoid

(2018) Kasper Katisko et al.   JOURNAL OF ALZHEIMERS DISEASE

Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition

(2017) Rebekah M. Ahmed et al.   JOURNAL OF ALZHEIMERS DISEASE

Low IDL-B and high LDL-1 subfraction levels in serum of ALS patients

(2017) J.B. Delaye et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target

(2017) B. Borroni et al.   Scientific Reports

Serum C-Reactive Protein as a Prognostic Biomarker in Amyotrophic Lateral Sclerosis

(2017) Christian Lunetta et al.   JAMA Neurology

Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany

(2017) Gabriele Nagel et al.   Scientific Reports

Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects

(2016) Emma Sudria-Lopez et al.   ACTA NEUROPATHOLOGICA

Effect of inflammation on HDL structure and function

(2016) Kenneth R. Feingold et al.   CURRENT OPINION IN LIPIDOLOGY

Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism

(2016) Rebekah M Ahmed et al.   LANCET NEUROLOGY

C9orf72 is required for proper macrophage and microglial function in mice

(2016) J. G. ORourke et al.   SCIENCE

Loss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease

(2016) Aaron Burberry et al.   Science Translational Medicine

Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA

(2016) Johannes Kettunen et al.   Nature Communications

C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production and glomerulonephropathy in mice

(2016) Amanda Atanasio et al.   Scientific Reports

Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics

(2015) Pasi Soininen et al.   Circulation-Cardiovascular Genetics

Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia

(2015) Alberto Benussi et al.   Frontiers in Aging Neuroscience

Effect of lipid profile on prognosis in the patients with amyotrophic lateral sclerosis: Insights from the olesoxime clinical trial

(2015) Muhammad K. Rafiq et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

The serum lipid profiles of amyotrophic lateral sclerosis patients: A study from south-west China and a meta-analysis

(2015) Rui Huang et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Cardiovascular Epidemiology and Genetics

(2015) Pasi Soininen et al.   Circulation-Cardiovascular Genetics

Frontotemporal dementia and its subtypes: a genome-wide association study

(2014) Raffaele Ferrari et al.   LANCET NEUROLOGY

Lipid Integration in Neurodegeneration: An Overview of Alzheimer’s Disease

(2014) Rajesh Singh Yadav et al.   MOLECULAR NEUROBIOLOGY

Systemic metabolism in frontotemporal dementia

(2014) R. M. Ahmed et al.   NEUROLOGY

Cholesterol, Oxysterol, Triglyceride, and Coenzyme Q Homeostasis in ALS. Evidence against the Hypothesis That Elevated 27-Hydroxycholesterol Is a Pathogenic Factor

(2014) Anna Wuolikainen et al.   PLoS One

Hypolipidemia in Patients with Amyotrophic Lateral Sclerosis: A Possible Gender Difference?

(2013) Ji Won Yang et al.   Journal of Clinical Neurology

TDP-43 frontotemporal lobar degeneration and autoimmune disease

(2013) Z. A. Miller et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations

(2012) J. S. Snowden et al.   BRAIN

Long-term Leisure-time Physical Activity and Serum Metabolome

(2012) Urho M. Kujala et al.   CIRCULATION

Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases

(2012) J. E. Vance   Disease Models & Mechanisms

Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study

(2012) Elisa Majounie et al.   LANCET NEUROLOGY

Genome-wide association study identifies multiple loci influencing human serum metabolite levels

(2012) Johannes Kettunen et al.   NATURE GENETICS

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS

(2011) Mariely DeJesus-Hernandez et al.   NEURON

A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD

(2011) Alan E. Renton et al.   NEURON

Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis

(2010) J. Dorst et al.   JOURNAL OF NEUROLOGY

Relationship Between Low Levels of High-Density Lipoprotein Cholesterol and Dementia in the Elderly. The InChianti Study

(2010) G. Zuliani et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism

(2009) Pasi Soininen et al.   ANALYST

The heritability and genetics of frontotemporal lobar degeneration

(2009) J. D. Rohrer et al.   NEUROLOGY

Lower serum lipid levels are related to respiratory impairment in patients with ALS

(2009) A. Chio et al.   NEUROLOGY

Role of MAPT mutations and haplotype in frontotemporal lobar degeneration in Northern Finland

(2008) Anna-Lotta Kaivorinne et al.   BMC Neurology

Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration

(2008) J. Krüger et al.   EUROPEAN JOURNAL OF NEUROLOGY

Dyslipidemia is a protective factor in amyotrophic lateral sclerosis

(2008) L. Dupuis et al.   NEUROLOGY